Nisa Investment Advisors
VRDN icon

Nisa Investment Advisors’s Viridian Therapeutics VRDN Stock Holding History

Nisa Investment Advisors’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Buy
1,698
+695
+69% +$11.2K ﹤0.01% 2046
2026
Q1 		$19.6K Buy
1,003
+3
+0.3% +$89 ﹤0.01% 2019
2025
Q4 		$31.1K Sell
1,000
-205
-17% -$5.62K ﹤0.01% 1777
2025
Q3 		$26K Hold
1,205
– – ﹤0.01% 1869
2025
Q2 		$16.8K Sell
1,205
-122
-9% -$1.66K ﹤0.01% 2025
2025
Q1 		$17.9K Buy
1,327
+86
+7% +$1.47K ﹤0.01% 1927
2024
Q4 		$23.8K Buy
1,241
+193
+18% +$4.2K ﹤0.01% 1885
2024
Q3 		$23.8K Sell
1,048
-84
-7% -$1.37K ﹤0.01% 1858
2024
Q2 		$14.7K Buy
1,132
+1,057
+1,409% +$14.6K ﹤0.01% 2043
2024
Q1 		$1.31K Buy
75
+45
+150% +$872 ﹤0.01% 2315
2023
Q4 		$653 Buy
30
+10
+50% +$158 ﹤0.01% 2355
2023
Q3 		$307 Sell
20
-865
-98% -$16.5K ﹤0.01% 2609
2023
Q2 		$21.1K Buy
885
+240
+37% +$6.16K ﹤0.01% 2081
2023
Q1 		$16K Buy
645
+620
+2,480% +$19.9K ﹤0.01% 2073
2022
Q4 		$1K Buy
+25
New +$576 ﹤0.01% 2527

Other funds holding VRDN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Nisa Investment Advisors's VRDN Position: Q2 2026 in Review

Nisa Investment Advisors increased its Viridian Therapeutics (VRDN) stake by 69% in Q2 2026, buying an estimated $11.2K and bringing the position to 1,698 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

Nisa Investment Advisors first reported a position in VRDN in Q4 2022 and has held it in 15 quarters since. 71 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • Nisa Investment Advisors held 1,698 shares of Viridian Therapeutics worth $31.2K as of Q2 2026.
  • Nisa Investment Advisors bought 695 Viridian Therapeutics shares in Q2 2026, an estimated $11.2K.
  • Viridian Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2046 holding.
  • Nisa Investment Advisors first reported a position in Viridian Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 71 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.